Document › Details
Bruker Corporation. (5/19/09). "Press Release: Bruker Expands the Boundaries of Ultra-high Performance Mass Spectrometry with the Introduction of solariX, the Next-generation FTMS Platform. A 10-fold Sensitivity Jump, Broad-based Mass Resolution of >1,00
Bruker Daltonics today launched the solariX™, its next generation hybrid Qq-FTMS platform. The solariX is the culmination of a number of key technology developments that deliver unique capabilities and unparalleled ultra-high resolution mass spectrometry performance and versatility. At the core of these innovations are dramatically improved broad-band mass resolving power (8x over earlier platforms), sensitivity (> 10x over earlier platforms) and dynamic range. These dramatic improvements help address today's most challenging top-down proteomics and complex mixture applications.
Its broad-band, ultra-high resolving power (> 1,000,000 @ m/z 400, for a 7 tesla instrument) and outstanding sub-ppm mass accuracy make the solariX more powerful than any previous mass spectrometer for the analysis of extremely complex mixtures. This extraordinary increase in the number of available m/z channels is essential for tackling very complex mixtures, especially those that are not amenable to high-resolution chromatography separation techniques. These applications can include: hydrocarbon related analysis ("petroleomics"), environmental soil/sediment analysis, small-molecule biological tissue MALDI imaging, metabolomics, and the inherently complex peak patterns resulting from top-down proteomics.
For applications that require high performance LC-FTMS or LC-MS/FTMS, the solariX offers faster and smart data-dependent acquisition capabilities. Moreover, sub-ppm mass accuracy is maintained throughout the LC-MS analysis using Bruker's proprietary Ion Charge Control (ICC™) method.
Adding to the existing arsenal of top-down proteomics structural fragmentation tools (ECD, Q-CID, in-cell SORI-CID), solariX is now the first FTMS system with Electron Transfer Dissociation (ETD). This exciting new technique is superb for in-depth, comprehensive analysis of proteins and peptides and their labile, post-translational modifications (PTMs). ETD-analysis has been fully automated and can be combined with LC-MS/FTMS workflows in combination with quadrupole fragmentation (Q-CID) to provide unprecedented levels of protein structural information. The solariX can also be easily incorporated into the workflows of other mainstream proteomics platforms such as the new Bruker ultrafleXtreme MALDI-TOF/TOF (for high throughput biomarker discovery/quantitation and Edmass™ protein sequencing) and amaZon ion trap (for high-throughput LC-MS/MS). The solariX provides complementary analytical capabilities through the combination of unique dissociation tools with the performance necessary to address the most challenging structural or functional proteomics applications, including protein structural studies and PTM characterization.
The new dual ion funnel source combined with a unique rf ion transfer system makes the solariX FTMS as intuitive and easy to use as a benchtop ion trap mass spectrometer. Operation of the instrument is performed using Bruker's unified Compass™ software, enabling researchers to harness the analytical power and versatility of FTMS with ease.
The solariX can be configured with a unique dual ESI/MALDI source, and a range of API source options (APCI, GC-APCI, APPI). Low maintenance, refrigerated magnets are standard at several magnetic field options, including 7T, 9.4T, 12T and 15T. The solariX is the realization of the highest performance FTMS product ever released to the marketplace, equally well suited for small molecule or protein applications.
Professor André Deelder (Leiden University Medical Center, Netherlands) commented: "Part of our mission is to leverage new, enabling technologies for life science research. Therefore, we are very excited to have received the first two solariX systems, which are 12 tesla and 15 tesla instruments. The advanced performance and added capabilities of solariX have been integrated into our proteomics and metabolomics workflows. They will increase our capacity for in-depth characterization and quantitative analysis of the large number of samples generally encountered in clinical studies, and will enable us to identify more proteins with very high quantitative precision."
Professor Michael Gross (Washington University, St. Louis, MO) stated: "Our work in top-down protein characterization will greatly benefit from the enhanced sensitivity and ETD capabilities of the solariX FTMS. We have purchased the solariX 12T system and are very much looking forward to having it in our laboratory."
The solariX will be highlighted at Bruker's Annual Users Meeting on Sunday, May 31st, 2009 before the 57th ASMS Conference on Mass Spectrometry in Philadelphia, PA. For more information on this event, please visit www.bdal.com/asms2009 . For further product information, please visit www.bdal.com/solariX .
ABOUT BRUKER DALTONICS: For more information about Bruker Daltonics and Bruker Corporation (NASDAQ: BRKR), please visit www.bdal.com and www.bruker.com.
Darwin Asa, Ph.D., +1 978-663-3660, ext. 1149
Life-Science Marketing Manager
Record changed: 2016-03-19
More documents for Bruker Corporation (Group)
-  Bruker Corporation. (1/4/17). "Press Release: Bruker Announces Acquisition of CMO InVivo Biotech to Expand Molecular Biology, Microbiology and Pathology Consumables and Assay Business". Berlin....
-  Bruker Corporation. (1/4/17). "Press Release: Bruker Announces Acquisition of SCiLS GmbH to Advance MALDI Imaging Software Solutions for Life Science, Pharma and Pathology Research Applications". Bremen....
-  Bruker Corporation. (1/3/17). "Press Release: Bruker Corporation to Present at the 35th Annual J.P. Morgan Healthcare Conference". Billerica....
-  Bruker Corporation. (12/21/16). "Press Release: Bruker Delivering 300 Hand-held Chemical Detectors to German BBK". Leipzig....
-  Bruker Corporation. (12/16/16). "Press Release: Bruker Announces Acquisition of Active Spectrum Micro-ESR Business". Billerica, MA....
-  Bruker Corporation. (12/2/16). "Press Release: Bruker Announces Corporate Partnership with International Phenome Centre Network (IPCN) for NMR Technologies and SOPs". Billerica, MA....
-  Bruker Corporation. (11/28/16). "Press Release: Bruker AXS Introduces a New Member to the D8 ADVANCE Family — the D8 ADVANCE Plus". Boston, MA....
-  Bruker Corporation. (11/22/16). "Press Release: Bruker Completes Acquisition of Preclinical PET Imaging Business". Billerica, MA....
-  Bruker Corporation. (11/17/16). "Press Release: Bruker and Oxford Instruments Announce Acquisition of Oxford Instruments Superconducting Wire Business by Bruker's BEST Segment". Billerica, MA & Tubney Woods....
-  Bruker Corporation. (11/16/16). "Press Release: Cetim Facility Receives Bruker Contour CMM Dimensional Analysis System". San José, CA & Senlis....
To subscribe to our free, monthly mass spectrometry newsletter, please send an e-mail to firstname.lastname@example.org and simply fill the subject line with the word »MSC newsletter«
To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]